ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, offering promising breakthroughs throughout many medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, additional responsible alternate for therapeutic use,